Feature | May 20, 2014

FDA Gathers Information on How to Regulate 3-D Printing of Medical Devices

Workshop will look at technical considerations for printing medical devices on demand

3-d pronting, 3D printing

The University of Arizona is using 3-D printing of pediatric patients chest cavities and organs to confirm if the Syncardia ventricular assist device (VAD) can fit in specific patients.

May 20, 2014 — It is possible to use 3-D printer technology to create some types of customized medical devices on demand, and some research centers are developing technology to print more complex devices like heart valves using biocompatible materials. The Food and Drug Administration (FDA) has recognized the technology now exists to print these types of devices and is gathering information regarding technical assessments that should be considered when it will inevitably begin reviewing these types of future FDA submissions.

The FDA will host a workshop titled “Additive Manufacturing of Medical Devices: An Interactive Discussion on the Technical Considerations of 3-D Printing,” Oct. 8-9, 2014, from 8 a.m. to 5 p.m. in Silver Spring, Md. The purpose of this workshop is to provide a forum for FDA, medical device manufactures, additive manufacturing companies and academia to discuss technical challenges and solutions of 3-D printing. 

Additive manufacturing, also known as 3-D printing, is a fast- growing manufacturing technique that builds devices from computerized blueprints or models, by layering material only where it is needed as if building with interlocking bricks. Traditional methods of manufacturing remove material from larger pieces by cutting, drilling, and carving to create a final part. Through additive manufacturing designers can alter products quickly for rapid prototype iteration or produce small batches of multiple product designs in each batch. The 3- D computer models used to build each part can be created using traditional computer-aided design techniques or they can be made directly from 3-D image sources, such as computed tomography (CT) scans or magnetic resonance imaging (MRI). Designers can also use a combination of techniques. Consequently, the FDA said 3-D printers can create truly anatomically matched devices or surgical guides by utilizing a patient's own medical imaging. 
 
Additive manufacturing is just beginning to enter mainstream use in medical devices. The FDA said this technology unlocks new avenues for creativity and innovation for medical device designers. For example, the FDA said it can facilitate the production of devices with intricate structures that were previously impractical or impossible. Current industry applications include using it as an alternative device production method for traditional components or as a primary method to create patient-matched devices. As the technology matures, additional capabilities may be incorporated into medical devices. 
 
FDA said it already has begun to receive submissions using additive manufacturing for both traditional and patient-matched devices, and it sees many more on the horizon. Industry forecasts project significant growth of additive manufacturing in both traditional and innovative environments by 2025.   
 
Additive manufacturing may or may not present new questions depending on its use. However, the FDA said it realizes there are technical challenges associated with the process from design to final product that need to be properly addressed in all cases to ensure patient safety and to promote innovation in a fast-moving field. Process verification and validation are especially important when devices are produced individually or in very small batches. 
 
By discussing and addressing these technical challenges through an open forum, FDA would like to foster innovation with a transparent process and shared expectations for stakeholders. Participants in the October workshop will include researchers, scientists and engineers involved with the research and development of products using additive manufacturing as one or more steps of the manufacturing process. The intent is to address scientific and technical challenges posed by additive manufacturing process, but not address specific printing technologies or medical device types. The latter will still be covered by their respective standards and guidance documents. Ideas generated during this workshop may facilitate development of new draft guidance and/or standards for additive manufacturing of medical devices. 
 
The FDA said it will include discussions on several topics, including preprinting considerations, including material chemistry, physical properties, recyclability, part reproducibility and process validation. Printing considerations will include printing process characterization, software used in the process, post-processing steps such as curing, and  additional machining. Post-printing considerations will include cleaning/excess material removal, effect of complexity on sterilization and biocompatibility, final device mechanics, design envelope and verification. 
 
For more information: http://www.gpo.gov/fdsys/pkg/FR-2014-05-19/html/2014-11513.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery
 
 

Related Content

AHA and ACC Publish New Data Dictionary for Ambulatory EHRs in Pediatric and Congenital Cardiology
News | Congenital Heart| July 19, 2017
July 19, 2017 — The American Heart Association (AHA) and the American College of Cardiology (ACC) recently published
Sponsored Content | Videos | Cardiovascular Surgery| July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
First Patient Treated in U.S. Feasibility Study of LimFlow Critical Limb Ischemia Device
News | Peripheral Arterial Disease (PAD)| July 17, 2017
LimFlow SA announced enrollment of the first patient in the U.S. feasibility study of the LimFlow Percutaneous Deep...
FDA Approves Six-Month Primary Endpoint for Tack Endovascular System in Below the Knee Disease
News | Stents Peripheral| July 14, 2017
Intact Vascular Inc. announced the U.S. Food and Drug Administration (FDA) approved an Investigational Device Exemption...
Edwards Sapien 3 TAVR valve will be implanted in asymptomatic aortic stenosis patients in the EARLY TAVR Trial
Feature | Heart Valve Technology| July 14, 2017
July 14, 2017 — Morristown Medical Center, part of Atlantic Health System, has randomized the first patient in the wo
long-duration dual anti-platelet therapy (L-DAPT) compared to short-duration dual antiplatelet (S-DAPT) after DES stent implantation
News | Antiplatelet and Anticoagulation Therapies| July 12, 2017
June 12, 2017 — Researchers have evaluated the long-term efficacy and safety of long-duration dual anti-platelet ther
Medtronic's CoreValve Evolut R gained FDA approval for intermediate risk patients

An illustration of the self-expanding CoreValve Evolut R TAVR valve half deployed in the aortic root.

Feature | Heart Valve Technology| July 10, 2017
The U.S. Food and Drug Administration (FDA) has cleared an additional indication to expand the use Medtronic's self-...
Patient Race, Gender Both Important in Predicting Heart Attack Symptoms in the ER
News | Cath Lab| July 07, 2017
Researchers at the George Washington University (GW) found that certain symptoms are more and less predictive of...
ACCESS PTS Study Demonstrates Efficacy of EKOS Therapy for Post-Thrombotic Syndrome
News | Deep Vein Thrombosis| July 07, 2017
BTG plc recently highlighted the results of the ACCESS PTS trial, presented at the Society for Vascular Medicine 28th...
GE Additive and Stryker Announce Additive Manufacturing Partnership
News | 3-D Printing| July 06, 2017
GE Additive and Stryker have entered a partnership agreement to support Stryker’s growth in additive manufacturing. The...
Overlay Init